https://globiox.com/ 2025-06-13T14:00:13-05:00 https://globiox.com/step-by-step-strategies-for-effective-rems-audit-preparation/ 2024-06-26T12:01:29-05:00 https://globiox.com/staying-ahead-navigating-timely-training-and-version-control-in-pharmaceuticals-and-medical-devices/ 2024-03-12T13:24:55-05:00 https://globiox.com/event-register-today-for-building-a-medical-device-quality-management-system-with-limited-resources/ 2024-03-04T14:39:25-06:00 https://globiox.com/globiox-stands-up-and-stands-out-at-biofest-invest-2/ 2024-03-04T14:30:52-06:00 https://globiox.com/globiox-stands-up-and-stands-out-at-biofest-invest/ 2024-02-14T10:29:47-06:00 https://globiox.com/choosing-the-right-eqms-key-considerations-in-quality-managment-system-selection/ 2024-01-31T09:29:21-06:00 https://globiox.com/cultivating-peace-and-harmony-celebrating-a-year-of-impact-in-life-science/ 2023-12-15T12:24:37-06:00 https://globiox.com/globiox-launches-free-consultations/ 2021-05-21T12:11:24-05:00 https://globiox.com/fdas-data-integrity-citation-trends-of-biological-products/ 2020-03-25T14:51:29-05:00 https://globiox.com/september-office-hours-at-the-university-of-texas-dell-medical-school-colab/ 2019-09-11T11:02:41-05:00 https://globiox.com/challenges-of-the-medical-device-market-for-new-manufacturers/ 2019-09-10T11:53:27-05:00 https://globiox.com/full-globioxs-office-hours-at-the-university-of-texas-dell-medical-school-colab/ 2019-08-14T11:12:05-05:00 https://globiox.com/globioxs-office-hours-at-the-university-of-texas-health-colab/ 2019-08-12T14:05:24-05:00 https://globiox.com/latest-updates-on-regulatory/ 2019-07-30T11:30:18-05:00 https://globiox.com/clinical-evaluation-reports-cer/ 2019-07-30T11:04:51-05:00 https://globiox.com/almost-there-safety-and-performance-pathway-option-for-510k-submissions/ 2019-07-30T11:07:12-05:00 https://globiox.com/equipment-validation-is-not-process-validation/ 2019-02-22T09:35:28-06:00 https://globiox.com/fda-plans-major-overhaul-looks-to-be-more-specialized/ 2019-02-22T09:35:46-06:00 https://globiox.com/we-do-what-we-do-for-a-reason/ 2019-02-22T09:36:13-06:00 https://globiox.com/cgmp-now-includes-supply-chain-management/ 2019-02-22T09:36:44-06:00 https://globiox.com/the-fdas-dos-and-donts-for-responding-to-a-483/ 2019-02-22T09:37:26-06:00 https://globiox.com/design-control/ 2019-02-22T09:37:46-06:00 https://globiox.com/high-frequency-of-capa-related-observations-in-warning-letters/ 2019-02-22T09:38:27-06:00 https://globiox.com/dont-let-the-user-manual-become-the-user/ 2019-02-22T09:38:55-06:00 https://globiox.com/combined-use-diagnostic-instruments-and-the-fdas-thoughts/ 2019-02-22T09:40:12-06:00 https://globiox.com/what-happens-when-you-cant-test-a-test/ 2019-02-22T09:39:38-06:00 https://globiox.com/keeping-up-with-the-fda/ 2019-02-22T09:39:20-06:00 https://globiox.com/warning-letters-what-they-are-how-we-can-help/ 2018-12-19T15:01:50-06:00 https://globiox.com/fda483/ 2018-12-19T14:59:26-06:00 https://globiox.com/embed-ilist/ 2025-05-07T23:45:05-05:00 https://globiox.com/training/ 2025-07-07T10:16:58-05:00 https://globiox.com/company/ 2025-06-16T10:50:41-05:00 https://globiox.com/auditing/ 2025-07-07T10:17:24-05:00 https://globiox.com/trackwise-services/ 2025-06-13T13:46:16-05:00 https://globiox.com/our-team/ 2025-06-17T05:33:25-05:00